Company Filing History:
Years Active: 2021
Title: Innovations by Kristopher Michael Kirmess
Introduction
Kristopher Michael Kirmess is an accomplished inventor based in St. Louis, MO. He has made significant contributions to the field of biomolecular measurement, particularly in relation to neurological and neurodegenerative diseases. His work focuses on developing methods that enhance the understanding of biomolecules in biofluids.
Latest Patents
Kirmess holds a patent for "Methods for measuring concentrations of biomolecules in biofluids." This invention provides innovative methods for measuring the absolute concentration of Tau and other protein, peptide fragments, and proteoforms in cerebrospinal fluid (CSF) and plasma samples. These biomolecules are crucial for understanding various neurological conditions. The patent also includes methods for determining the effects of therapeutic agents on biomolecule concentrations, along with kits designed for these methods.
Career Highlights
Kirmess is associated with C2n Diagnostics LLC, where he applies his expertise in biomolecular research. His work at the company emphasizes the importance of accurate biomolecule measurement in clinical settings. Kirmess's dedication to advancing medical diagnostics has positioned him as a key figure in his field.
Collaborations
Kirmess collaborates with notable colleagues, including Kevin Edward Yarasheski and Matthew R Meyer. Their combined efforts contribute to the innovative research and development at C2n Diagnostics LLC.
Conclusion
Kristopher Michael Kirmess is a prominent inventor whose work in measuring biomolecules has the potential to impact the diagnosis and treatment of neurological diseases. His contributions to the field are invaluable and continue to pave the way for future innovations.